Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Principia Biopharma Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 13 Aug 2021 | Principia Biopharma Inc Enters Phase II Clinical Trial Agreement with Collaborative Neuroscience Network LLC for atuzabrutinib (GDCT0429188) | Contract Service Agreement |
Principia Biopharma Inc
|
Collaborative Neuroscience Network LLC
|
| 17 Aug 2020 | Sanofi Acquires Principia Biopharma | Acquisition |
Sanofi
|
Principia Biopharma Inc |
| 25 Jun 2020 | Principia Biopharma Inc Enters Phase I Clinical Trial Agreement with Syneos Health Inc for atuzabrutinib (GDCT0391226) | Contract Service Agreement |
Principia Biopharma Inc
Principia Biopharma Inc Principia Biopharma Inc |
Syneos Health Inc Syneos Health Inc Syneos Health Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer